Geron Corp. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp.

GERN 1.145

+2.2%

10:16 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: bob zagorin	6/19/2008 11:34:06 AM
	of 3576

Hot Stocks story about IVGN The International Regulome Consortium announced it has signed a non-binding letter of intent with Invitrogen Corporation to develop tools for stem cell research that will aid in the development of new therapies for some of the world's most debilitating diseases. The agreement was signed here yesterday at the annual meeting of the Biotechnology Industry Organization. Invitrogen will contribute services and technology to help IRC researchers in their goal of mapping the genetic circuit board that regulates how stem cells give rise to specialized cells such as neurons. IRC is a third generation genome project, involving 58 researchers from 34 institutions in 12 countries. :theflyont

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next